Transdermal Skin Patch Market

Transdermal Skin Patch Market aims to provide a comprehensive presentation of the global market for Transdermal Skin Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal Skin Patch. Transdermal Skin Patch Market contains market size and forecasts of Transdermal Skin Patch in global, including the following market information:
Global Transdermal Skin Patch Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Transdermal Skin Patch Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Transdermal Skin Patch companies in 2022 (%)
The global Transdermal Skin Patch market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Fentanyl Transdermal Skin Patch Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Transdermal Skin Patch include Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, Actavis, Mundipharma, Henan Lingrui Pharmaceutical and Changzhou Siyao, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Transdermal Skin Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Transdermal Skin Patch Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, by Type, 2022 (%)
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Global Transdermal Skin Patch Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, by Application, 2022 (%)
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
Global Transdermal Skin Patch Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Transdermal Skin Patch Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Transdermal Skin Patch revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Transdermal Skin Patch revenues share in global market, 2022 (%)
Key companies Transdermal Skin Patch sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Transdermal Skin Patch sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Transdermal Skin Patch, market overview.
Chapter 2: Global Transdermal Skin Patch market size in revenue and volume.
Chapter 3: Detailed analysis of Transdermal Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Transdermal Skin Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Transdermal Skin Patch capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.